Skip to main content
. 2019 Aug 2;98(31):e16649. doi: 10.1097/MD.0000000000016649

Figure 4.

Figure 4

During the 16-mo follow-up, (A) The abnormal T lymphocytes in the peripheral blood and bone marrow were improved after the treatment of 100 mg cyclosporine A q12h, but in 2017.8, the peripheral abnormal T lymphocytes have a rebound and the plasma concentration of cyclosporine A was low so the dose was adjusted to 150 mg q12h and the peripheral abnormal T lymphocytes decreased again; (B) The titer of the anti-GBM antibody returned normal. GBM = glomerular basement membrane.